HepatoPredict (medical device) registration
Another important step in the development of HepatoPredict and an occasion for celebration: HepatoPredict is now a registered medical device under the DIRECTIVE 98/79/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 27 October 1998 on in vitro diagnostic medical devices.
HepatoPredict presented at the ESA Meeting
Our collaborator from the Cento Hospital Universitário de Lisboa Central (Hospital Curry Cabral) presented an oral communication and discussed our work on predicting relapse after liver transplantation to treat hepatocellular carcinoma at the 28th anual meeting of the European Surgical Association. Lots of discussion and interest.
Ophiomics presenting HepatoPredict at the ILTS Annual meeting
If you are attending the annual meeting of the International Liver Transplantation Society, come hear about HepatoPredict on Saturday morning, Room 1 – Joana Vaz, PhD, our CSO and co-founder, will present the first batch of clinical validation results.